Non-Traditional Antimicrobials Can Follow Regulatory Path Laid By Small Molecule Antibiotics, US FDA Says

Pew AMR
Officials from US FDA's veterinary, drugs, devices and biologics centers discuss initiatives to spur new antimicrobial product development. • Source: Photo by Sue Sutter
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Approval Standards

More from Pathways & Standards